Author:
Miller Dylan V.,Kfoury Abdallah G.
Publisher
Springer International Publishing
Reference21 articles.
1. Berry GJ, Burke MM, Andersen C, et al. The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2013;32(12):1147–62.
2. Billingham ME, Cary NRB, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Transplant. 1990;9:587–92.
3. Book WM, Kelley L, Gravanis MB. Fulminant mixed humoral and cellular rejection in a cardiac transplant recipient: a review of the histologic findings and literature. J Heart Lung Transplant. 2003;22(5):604–7.
4. Fedrigo M, Feltrin G, Frigo A, Toscano G, Tona F, et al. Mixed acute cellular rejection and antibody mediated rejection in heart transplantation: a retrospective study in a single transplant center. J Heart Lung Transplant. 2014;33(4S):S113.
5. Fedrigo M, Leone O, Burke MM, Rice A, Toquet C, et al. Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP. Am J Transplant. 2015;15(2):526–34.